But those taking a GLP-1 for weight loss may think about reducing their dose or even stopping completely once they reach their goal weight
doi: 10.1111/dom.12076
According to JRNYS materials, options include semaglutide (the active ingredient in Ozempic and Wegovy), tirzepatide (the active ingredient in Mounjaro and Zepbound), and liraglutide (the active ingredient in Saxenda)
Combining weight-loss products can increase side effects or interactions, and an outside program may duplicate clinical care or lab costs
Managing common side effects Most GLP-1 side effects can be managed with simple, practical strategies
Superimpositions of the two tirzepatide- and three peptide 20-bound structures to the three receptors bound by the endogenous ligands (GIP, GLP-1 and GCG) showed that the five peptides all adopt a single continuous helix, with the well-overlapped N terminus penetrating to the TMD core stabilized by conserved interactions, while the C terminus anchors the ECD, ECL1 and ECL2 in a receptor- and ligand-specific manner